Skip to the news
Agewell GuideNEWS · Q2 2026Get the weekly briefing

Longevity news · updated July 27, 2026

Longevity news

Dated, sourced updates on longevity clinics, devices and research. Each one explains what changed and whether it should change what you buy, book or skip.

Empty clinical consultation room representing the closure of a longevity clinic

Eternal closes its U.S. longevity clinics, citing an unsustainable business model

Eternal, which raised $13 million to deliver DEXA scans, VO2 max testing and physician-led programs across San Francisco and New York, announced July 14 that both clinics would close at the end of the month. CEO Alex Mather said the company could not build a sustainable business despite exploring digital care and AI-coaching pivots. Before joining any longevity clinic, the standard due-diligence question is now worth asking explicitly: what happens to your records, referrals and follow-up protocols if the clinic closes - a physician-staffed, venture-backed operation can fold in under two years.

Source · Fitt Insider – Eternal Shuts Down Its High-Performance Health Platform →
Journal of Alzheimer's Disease March 2026 paper on heat exposure and Alzheimer's resilience

A case report links heat exposure to Alzheimer's resilience - one patient, not a trial

A March 2026 paper in the Journal of Alzheimer's Disease describes a single patient carrying a PSEN2 mutation for early-onset Alzheimer's who maintained cognitive function despite high amyloid burden, with the authors hypothesizing that lifelong occupational heat exposure promoted tau clearance through improved protein homeostasis. The study is a case report of one individual, not a controlled trial, and it establishes a hypothesis, not a treatment. Clearlight infrared saunas issued a press release on July 15 citing the paper and has been selected to supply equipment for a follow-on clinical study, which is the commercial framing to read past. The authors state that the paper does not establish that infrared sauna use prevents or treats Alzheimer's disease.

Source · Canet et al. - Journal of Alzheimer's Disease, March 2026 →

Fountain Life launches a $595/year membership. Ask what it excludes

Independent coverage reported Fountain Life’s new BASE membership at $595 per year, far below its five-figure APEX membership. BASE includes more than 100 blood biomarkers, a DEXA scan, clinician-guided review and digital tracking, but availability and any extra charges still need confirmation. Ask for the current written tier comparison and a complete first-year price before joining.

Source · Longevity.Technology – Fountain Life introduces BASE at $595 →

FDA ends its WHOOP warning: wearable blood-pressure estimates remain wellness data

The FDA closed its warning to WHOOP on June 23, 2026 after the company changed how Blood Pressure Insights is presented. The feature remains a general-wellness estimate, not a medical blood-pressure reading. Use a validated upper-arm cuff for clinical decisions.

Source · MedTech Dive – FDA drops WHOOP warning letter over blood pressure feature →

First wearable cortisol sensor shows in-human proof-of-concept at ADA, not yet cleared

A wearable patch that reads free cortisol from dermal interstitial fluid tracked paired venous blood measurements in a controlled hydrocortisone challenge, Adaptyx Biosciences reported at the American Diabetes Association's 86th Scientific Sessions on June 9, 2026, with more than 400 hours of IRB-approved in-body monitoring as the evidence base. The sensor uses a 16-channel array with cortisol-specific molecular switches to capture the hormone's daily rhythm at minute resolution, which no blood, saliva, or urine test can replicate continuously. Cortisol governs glucose control, cardiovascular stress response, and sleep quality; continuous wearable monitoring could give the longevity-tracking stack a signal that a one-time morning blood draw misses entirely. The device is pre-commercial and pursuing an FDA Class II pathway, not yet cleared; if the regulatory arc resembles the CGM category, commercial availability is at least a few years out.

Source · BusinessWire – Adaptyx Biosciences ADA press release, June 2026 →

Oura Ring 5 costs $399; its blood-pressure signal is not a medical reading

Oura Ring 5 began shipping June 4, 2026 at $399, with a thinner design and a claimed six to nine days of battery life. Its new blood-pressure signal is not an FDA-cleared monitor. Treat it as a trend flag until independent clinical validation is available, and use a validated cuff for actual blood-pressure readings.

Source · BusinessWire – Oura Ring 5 announcement →

FDA extends Stelo OTC CGM to children ages 2 and up: access wider, clinical scope unchanged

On June 12, 2026, the FDA cleared the Dexcom Stelo Glucose Biosensor System for over-the-counter use by people ages two and older who do not use insulin, expanding the original March 2024 adult clearance to pediatric users. The hardware is the same: a 15-day wearable sensor delivering 15-minute glucose readings via smartphone, with adults required as caregivers for child users. The clearance is an access decision, not a shift in evidence: the label excludes insulin-dependent users and does not endorse Stelo as a long-term health monitor for metabolically healthy children. The buyer logic that applied to adults, a short-window audit rather than an open subscription, applies at least as much here.

Source · FDA – Stelo OTC clearance extended to ages 2+ →

OTC CGMs, two years in: the glucose habit still has to earn its keep

Context, not news: the FDA cleared Dexcom Stelo in March 2024 as the first over-the-counter CGM for adults who do not use insulin, including non-diabetics who want diet-and-exercise feedback. Two years on, access is wide but the label is unchanged. It still tells users not to make medical decisions from the output without a clinician, and a useful two-week audit is not the same thing as a forever subscription.

Source · FDA – first OTC CGM clearance →

No smartwatch or ring measures glucose on its own, says FDA

The FDA safety communication is the line to remember: it has not authorized, cleared or approved any smartwatch or smart ring that measures or estimates blood glucose by itself. A watch can display data from a real CGM; it is not the sensor.

Source · FDA – glucose smartwatch warning →

Google launches $99 screenless Fitbit Air into the tracker market

Google released the Fitbit Air on 26 May 2026 at $99.99, a screenless band that delivers HRV monitoring, sleep analysis, and AFib detection at a lower entry price than WHOOP (no device ownership, roughly $199/yr) or Oura (roughly $349 hardware plus $70/yr subscription). No independent accuracy validation has been published for this device yet; the pattern across current wearables is that resting heart rate and HRV read close to clinical reference, while sleep staging barely clears a coin toss against polysomnography. The lower price lowers the stakes for experimentation, not the evidential bar for longevity outcomes.

Source · Google Blog – Introducing Fitbit Air →

The red-light irradiance number you’re sold runs 2–3× high

Independent spectrometer testing keeps landing the same way: the irradiance brands advertise – measured on cheap solar meters – runs two to three times the real figure, and almost no panel clears ~90 mW/cm² at six inches when measured properly. Buy on the measured number, at a stated distance, not the box.

Source · Light Therapy Insiders →

FDA flags hyperbaric chamber fires and off-label aging claims

The FDA’s 2025 guidance to clinicians ties hyperbaric oxygen devices to fires causing serious injuries and deaths, and flags centers promoting unapproved aging and longevity uses. HBOT is not cleared for aging-reversal claims – and the home soft-shell at 1.3 ATA is not the 2.0 ATA dose the longevity studies used.

Source · FDA – Letters to Health Care Providers →

The Agewell Briefing

The longevity news worth your time, once a week.

A sourced weekly read on longevity products, clinics and research, with a clear answer on what is worth trying.

One email a week. Unsubscribe with one click.